2015

ICON acquires PMG Research

Monday, December 7, 2015

ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has announced the acquisition of PMG Research, an integrated network of clinical research sites operating from 12 metropolitan areas throughout the U.S. The acquisition will enhance ICON’s ability to access and engage with investigator sites and patients, helping customers to reduce the overall time and cost associated with drug development.

[Read More]

Companion diagnostics are here to stay

Monday, December 7, 2015

The Pulse on Global Trials by Matthew Howes

The story of personalized medicine has evolved from folklore to popular science, and is destined to become classic medical literature.

[Read More]

Three Questions: Noah Craft, Science 37

Monday, December 7, 2015

CWWeekly presents this feature as a way to put the spotlight on issues faced by executives in the clinical trial space. Staff Writer Ron Rosenberg spoke to Noah Craft, M.D., Ph.D., co-founder of Los Angeles-based Science 37, which seeks to transform biomedical discovery and reduce clinical trial costs using a mobile research platform to simplify the process of participating in clinical studies.

[Read More]

Propeller deal echoes trend in wearable devices

Monday, December 7, 2015

The number of small, pilot clinical trials to evaluate new wearable devices continues to grow, as the once-untested technology is becoming another research tool for companies focused on developing new sensors for both handheld and wearable products.

[Read More]